Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@BlogYomi 9
@thefinreviewer 7
@TheMarketsDaily 4
@bibeypost_stock 4
@macondailynews 3

Recent Tweets for FATE

JRMKE_ @JRMKE_
@TomSilver39 Are you sure $FATE is presenting here? I didn’t hear anything during their latest CC about this confer… https://t.co/hSdSiZhoRO
April 22nd 2019, 4:04pm
FinZTribune @FinZTribune
Ionis Pharmaceuticals Inc. $FATE https://t.co/VQkVgRx0IW
April 22nd 2019, 4:04pm
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $FATE $RRGB ... https://t.co/mnYaiRq1wk
April 22nd 2019, 11:04am
macondailynews @macondailynews
Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/6LtejWenmr
April 22nd 2019, 5:04am
stocknewstimes @stocknewstimes
Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/ZyKANpT8wX
April 22nd 2019, 4:04am
TranscriptDaily @TranscriptDaily
Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/iaTNGUnNqV
April 22nd 2019, 4:04am
macondailynews @macondailynews
Analysts Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/dWkmSldz8X
April 21st 2019, 10:04pm
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Expect Fate Therapeutics Inc $FATE Will Post Quarterly Sales of $2.94 Million https://t.co/rt3ruB7tDi
April 21st 2019, 10:04pm
dakotafinancial @dakotafinancial
Brokerages Expect Fate Therapeutics Inc $FATE Will Post Earnings of -$0.23 Per Share https://t.co/EVus8TTHwJ
April 21st 2019, 10:04pm
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics Inc $FATE CEO J Scott Wolchko Sells 8,541 Shares https://t.co/iL03it3jie
April 21st 2019, 5:04am
ZolmaxNews @ZolmaxNews
J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/sbnS45nobT
April 21st 2019, 5:04am
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $FATE https://t.co/J4oHx27FTs
April 21st 2019, 12:04am
1MinuteStock @1MinuteStock
Recommendation Moderate #SELL for $FATE with UB rating - 1.56 out of 5. https://t.co/b2bTDHWFZe
April 20th 2019, 11:04pm
ZG121015 @ZG121015
$FATE stochastic buy with hammer candle. https://t.co/UoqtMJn7CO
April 20th 2019, 8:04pm
dakotafinancial @dakotafinancial
Fate Therapeutics Inc $FATE CEO J Scott Wolchko Sells 8,541 Shares https://t.co/3QZPONlZ7x
April 20th 2019, 9:04am
ConsumerFeed @ConsumerFeed
Fate Therapeutics CEO J Scott Wolchko Sells $138,107.97 in $FATE https://t.co/s7hqdXixNN
April 20th 2019, 3:04am
insiderbuyings @insiderbuyings
$FATE new insider selling: 20000 shares. https://t.co/TtsVriQRXT
April 19th 2019, 10:04pm
ThisLincolnian @ThisLincolnian
Fate Therapeutics Inc $FATE CEO Sells $138,107.97 in Stock https://t.co/8viZbRKItS
April 19th 2019, 5:04pm
AmericanBanking @AmericanBanking
J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/ibq7dAJ0wX #stocks
April 19th 2019, 5:04pm
WeekHerald @WeekHerald
J Scott Wolchko Sells 8,541 Shares of Fate Therapeutics Inc $FATE Stock https://t.co/yjq58fL2zN
April 19th 2019, 5:04pm
InsiderAlertsIA @InsiderAlertsIA
$FATE: New Insider Filing on President and CEO J SCOTT WOLCHKO: https://t.co/9UQTN5EW9a
April 19th 2019, 4:04pm
EdgarPulse @EdgarPulse
$FATE: Wolchko J Scott (CEO) disposed stocks worth $321,641 https://t.co/b5K7Rn07dY
April 19th 2019, 4:04pm
dispatchtribune @dispatchtribune
-$0.23 EPS Expected for Fate Therapeutics Inc $FATE This Quarter https://t.co/4KAkvr1Eoz
April 19th 2019, 1:04pm
BlindSpotFunds @BlindSpotFunds
@B3_MillerValue When $FATE was bottoming, there were many internet blogger's, like @adamfeuerstein, pointing at it… https://t.co/9KEp2fpPUp
April 19th 2019, 1:04pm
WeekHerald @WeekHerald
Zacks: Brokerages Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/NXMTCv7CdY
April 19th 2019, 1:04pm
OlympiaReport @OlympiaReport
Fate Therapeutics Inc $FATE Expected to Post Quarterly Sales of $2.94 Million https://t.co/AOKn2BgISB
April 19th 2019, 1:04pm
TheMarketsDaily @TheMarketsDaily
Fate Therapeutics $FATE Trading Down 5.4% https://t.co/wSARRl01sT
April 19th 2019, 10:04am
macondailynews @macondailynews
Fate Therapeutics $FATE Trading Down 5.4% https://t.co/upM9h2MDLv
April 19th 2019, 10:04am
TradeFlags @TradeFlags
TD BUY $FATE at 16.02, Supp 15.61 Resis 18.45 R18 HiLo 71% T1Y 21 strong_buy 1.5 fwdPE -15.3 DIV N/A #Fate Thera… https://t.co/v3wfo9Yekp
April 18th 2019, 10:04pm
thefinreviewer @thefinreviewer
Reviewing Pluristem Therapeutics Inc. $FATE's results https://t.co/fVCoUm6dFn
April 18th 2019, 10:04pm
BlogYomi @BlogYomi
iBio Inc. $FATE Contrasting side by side https://t.co/CNJyZKkOSl
April 18th 2019, 10:04pm
American_Bulls @American_Bulls
$FATE the bull pattern is not confirmed. A new bull pattern is detected. https://t.co/uZaWMEAfZz
April 18th 2019, 7:04pm
BlogYomi @BlogYomi
Fate Therapeutics $FATE Share Price Rose While Polaris Venture Management Company Decreased by $7.80 Million Its S… https://t.co/SRqLD9rsMH
April 18th 2019, 3:04pm
reurope_stock @reurope_stock
Were Analysts Bullish Fate Therapeutics, Inc. $FATE This Week? https://t.co/q5wBW8uw5y
April 18th 2019, 10:04am
HottestStockNow @HottestStockNow
$FATE Makes Strategic Move https://t.co/7aIBrwE3GW
April 18th 2019, 9:04am
StockTexts @StockTexts
$FATE Fate Therapeutics Appoints Wayne Chu, M.D. as Vice President, Clinical Development Nasdaq:FATE https://t.co/ksvcc7f8Kw
April 18th 2019, 8:04am
thefinreviewer @thefinreviewer
Farallon Capital Management Stake in Fate Therapeutics $FATE Boosted as Market Valuation Rose; Paccar $PCAR Stake M… https://t.co/9FwgIdNr1h
April 18th 2019, 5:04am
TranscriptDaily @TranscriptDaily
Fate Therapeutics $FATE Trading Down 5.4% https://t.co/X4ZCG9bJjc
April 17th 2019, 7:04pm
American_Bulls @American_Bulls
$FATE apparently the bull pattern is not confirmed. Prices continue to fall. https://t.co/uZaWMEAfZz
April 17th 2019, 6:04pm
BlogYomi @BlogYomi
As Fate Therapeutics $FATE Valuation Rose, Polaris Venture Management Company Decreased by $7.80 Million Its Posit… https://t.co/BKy39iwwv6
April 17th 2019, 2:04pm
mmahotstuff1 @mmahotstuff1
Polaris Venture Management Company Cut Stake in Fate Therapeutics INC $FATE by $7.80 Million as Stock Rose https://t.co/K36tGakSET
April 17th 2019, 2:04pm
bibeypost_stock @bibeypost_stock
Fate Therapeutics INC $FATE Shareholder Polaris Venture Management Company Cut Its Holding https://t.co/05MyF0aLzh
April 17th 2019, 2:04pm
whatsonthorold2 @whatsonthorold2
Time to Buy Fate Therapeutics, Inc. $FATE After Today's Huge Decline? https://t.co/k2raSNoFeU
April 17th 2019, 1:04pm
ConsumerFeed @ConsumerFeed
Brokerages Expect Fate Therapeutics Inc $FATE to Announce -$0.23 EPS https://t.co/HlmUv2HZ1y
April 17th 2019, 5:04am
thefinreviewer @thefinreviewer
As Fate Therapeutics $FATE Market Valuation Rose, Polaris Venture Management Company Has Trimmed Its Holding by $7… https://t.co/LRtLd51tDK
April 17th 2019, 5:04am
BlogYomi @BlogYomi
Reviewing NanoString Technologies Inc. $FATE's results https://t.co/6sDjvK0WDy
April 16th 2019, 7:04pm
thefinreviewer @thefinreviewer
Intrexon Corporation $FATE Comparing side by side https://t.co/VQqeK4Y7wJ
April 16th 2019, 5:04pm
stocknewstimes @stocknewstimes
Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $2.94 Million https://t.co/9S9hbHJWzJ
April 16th 2019, 2:04am
AmericanBanking @AmericanBanking
Fate Therapeutics Inc $FATE Expected to Announce Quarterly Sales of $2.94 Million https://t.co/lyK1QwyppH #stocks
April 16th 2019, 2:04am
TranscriptDaily @TranscriptDaily
Brokerages Anticipate Fate Therapeutics Inc $FATE Will Announce Quarterly Sales of $2.94 Million https://t.co/2G0Nx4IaE4
April 16th 2019, 2:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.